In NSC-34 cells harboring this mutation (a cellular model of ALS), the sustained activity of TANK-binding kinase 1 is induced, and the formation of LC3-positive aggregates is increased (Medchalmi et al. 2021). The gene discussed is MAP1LC3A; the disease is amyotrophic lateral sclerosis.